Thus, CM derived from hypoxic A549 and H358 lung cancer cells treated with the MAGL inhibitors JZL184 and MJN110 inhibited HUVEC migration and tube formation, two crucial steps in angiogenesis. Here, MGLL is linked to lung carcinoma.